Throwing In A Little Corporate Governance III

The Chicago Tribune has a feature article (free regist. req’d) on the recent trend of requiring corporate governance reforms as part of the settlement of shareholder litigation. The article contains a list of prominent examples, including the Hanover Compressor settlement.

Quote of note: “Experts said companies’ willingness to make governance changes often depends on the situation. Firms dominated by a controlling shareholder or founding family, they said, are more likely to resist what they deem to be interference. Plaintiffs are more likely to succeed, experts said, in the worst cases of inattentive boards and companies that have cooked the books.”

Leave a comment

Filed under Settlement

EDS Motion To Dismiss Denied

A court in the E.D. of Tex. has denied the motion to dismiss in the securities class action against Electronic Data Systems Corp. (“EDS”). The suit alleges that EDS misrepresented company earnings and facts related to its multibillion-dollar Navy/Marine Corps Intranet contract. According to an article in Computerworld, the court found that the plaintiffs had established a “strong inference that defendants were extremely reckless in continuing to recognize any revenue on the project when they were allegedly pursuing a tactic of intentionally providing goods that did not meet contract specifications.”

Quote of note: “Lawyers for the shareholders presented a significant number of documents that the court upheld as evidence supporting the allegations against EDS. Among the documents was a May 6, 2002, e-mail from the N/MCI transition manager at the Naval Air Systems Command that outlined various software problems, a failure to provide remote access for 61% of the users that were testing the new intranet, and a lack of secure Web access and help desk support.”

Addition: The opinion is now available on Westlaw – In re Electronic Data Systems Corp. Securities and “ERISA” Litigation, 2004 WL 52088 (E.D. Tex. Jan. 13, 2004).

Leave a comment

Filed under Motion To Dismiss Monitor

The Public Pension Fund Factor

PricewaterhouseCoopers has released a study on the role of public pension funds in securities class actions. Notable results:

(1) The number of cases with public pension funds as lead plaintiff has steadily increased since the passage of the PSLRA in 1995 – from 4 cases filed in 1996 to 56 cases filed in 2002.

(2) Of the more than 100 active cases where a public pension fund is acting as lead plaintiff, 80% allege accounting issues.

(3) In 2003, 15 settlements averaging over $120 million were reached in cases where a public pension fund served as lead plaintiff — sixteen times the average value of the remaining 85 cases settled last year.

There are a lot of conclusions that could be drawn from this data, but it is certainly clear that public pension funds are taking the lead in large accounting fraud cases.

Leave a comment

Filed under Lead Plaintiff/Lead Counsel, Lies, Damn Lies, And Statistics

Loss Causation In The S.D.N.Y.

What is necessary to adequately plead loss causation in a securities fraud case continues to be the subject of contention in the S.D.N.Y., with a number of decisions addressing the issue over the past year. The New York Law Journal has an article (via law.com – free regist. req’d) on yet another loss causation decision in DeMarco v. Robertson Stephens, Inc., 2004 WL 512232 (S.D.N.Y. Jan. 9, 2004), the securities class action against Robertson Stephens over its Corvis Corp. stock recommendations.

The suit alleges that Robertson Stephens’ analysts made buy recommendations for Corvis stock to prop up the price until the firm and some of its executives could sell off their pre-IPO shares in the company (i.e., a variation on a “pump-and-dump” stock manipulation). The alleged scheme was revealed to the market when a May 2001 article in the New York Times reported the discrepancy between Robertson Stephens’ public recommendations and the sales by its executives. In his opinion, District Judge Lynch notes that the price of Corvis stock dropped 16% within a few days of the article.

On the issue of loss causation, the defendants argued that the plaintiffs’ loss was due to the general market downturn in telecommunications stock, not any alleged misrepresentations. The court agreed that the plaintiffs could not merely allege that the price of Corvis shares had been inflated to establish loss causation (there is a circuit split on this issue), holding that “it is unlikely that loss causation could be adequately alleged in every fraud-on-the-market case that successfully pleads transaction causation because in cases where an unforseeable intervening event causes the plaintiffs’ loss, there is no causal nexus between the loss and the misrepresentation.” In the instant case, however, the court found that “the bursting of the Corvis stock bubble could reasonable be construed, at least in part, as the market’s correction of an inflated stock price, pumped up in part by defendants’ false statements about its opinions.”

The court took pains to distinguish the case from the facially similar cases against Merrill Lynch that have been dismissed by Judge Pollack. On the issue of loss causation, Judge Lynch noted that, in contrast to the Merrill Lynch cases, “in this case there is evidence that disclosure of defendants’ scheme caused a further decline in the price of Corvis stock, even after the overall bubble had burst.”

Holding: Motion to dismiss Rule 10b-5 claim denied. A motion to dismiss the insider trading claim against a Robertson Stephens executive, however, was granted.

Quote of note: “On the facts in this case, the Court must conclude that plaintiffs have adequately alleged loss causation because the decline in stock price was a forseeable consequence of defendants’ fraudulent statements that allegedly inflated the price, because in an efficient market, revelation of the misrepresentations will lead inexorably to a price correction.”

Leave a comment

Filed under Motion To Dismiss Monitor

Biotech’s Disclosure Issues

Biotechnology companies are frequent defendants in securities class actions, with the plaintiffs’ allegations often focusing on statements related to the new drug approval process. An article in today’s Boston Globe notes that the Food and Drug Administration (“FDA”) and the SEC “are in talks to develop new guidelines on cooperation” concerning disclosure issues. Last summer, the FDA announced that it has begun making referrals to the SEC when it believes its discussions with a company are being misrepresented to the public markets.

Quote of note: “Just how the FDA and SEC should interact is among the most sensitive issues for biotechnology companies. Their fortunes depend largely on showing investors they are making progress getting approvals for drugs that can cost hundreds of millions of dollars to research. Yet many executives believe that the two agencies work at cross-purposes. While securities rules require wide disclosure, repeating all of the technical detail the FDA conveys about an experimental drug can make a stock extremely volatile, said Carl B. Feldbaum, president of the Biotechnology Industry Organization, a trade group in Washington. ‘I think we need to come up with a coherent system where biotech CEOs aren’t cross-cut, like logs, between the FDA and the SEC,’ Feldbaum said.”

Leave a comment

Filed under All The News That's Fit To Blog

The Atlanta Bar Speaks Out

The Atlanta Journal-Constitution has a feature article on securities class actions. The article profiles the viewpoints of two prominent local securities litigators.

Quote of note: “A fraction of the 200-plus public companies in Georgia have been sued by shareholders in recent years. But the list includes names like Coca-Cola, BellSouth, Mirant, WestPoint Stevens, and most recently, Amvescap’s Invesco Funds Group, and Friedman’s, one of the largest retail jewelry chains in the country. All are defendants in pending cases.”

Leave a comment

Filed under All The News That's Fit To Blog

Short Whoppers Do Count

The Ninth Circuit has issued an opinion in Employee Teamsters Local Nos. 175 and 505 Pension Trust Fund v. Clorox Co., 2004 WL 32963 (9th Cir. Jan. 7, 2004) that addresses discovery, the PSLRA’s safe harbor for forward-looking statements, and scienter issues.

An interesting part of the opinion deals with the plaintiff’s contention that the lower court “incorrectly held that knowingly false statements made by [an officer defendant] during her April 22 conference call are not actionable as long as they are short, and that it improperly relied on limited and general cautions to protect Clorox under the PSLRA’s safe harbor and the ‘bespeaks caution’ doctrine.” The Ninth Circuit disagreed, finding the basis for the district judge’s holding was that the forward-looking statements were accompanied by meaningful cautionary language, not the relative length of the statements. Although plaintiffs argued that the lower court should not have considered cautionary language contained in Clorox’s Form 10-K filing in making this determination, the appellate court found that the officer defendant had referenced the risk factors in the Form 10-K during the call and “the PSLRA does not require that the cautions physically accompany oral statements.”

Holding: Affirming grant of partial summary judgment and judgment on the pleadings.

Quote of note: “It is with respect to these statements that the court observed that [the officer defendant] ‘spoke only a couple of sentences and provided an approximate timetable.’ Investors submit that the court’s holding that ‘short whoppers don’t count’ is error, but we read its decision as turning on context rather than word count.”

Leave a comment

Filed under Appellate Monitor

Who Benefits From Class Action Reform?

The New York Lawyer has an article (via law.com – free regist. req’d) on the Class Action Fairness Act, which looks like it has a chance of passing in the Senate this year. The legislation applies some of the reform concepts in the PSLRA and SLUSA to all class actions. Notably, class actions meeting certain jurisdictional criteria would have to be heard in federal court. As in the field of securities class actions, one of the beneficiaries of the legislation will be large, national plaintiffs’ firms that have the resources to bring these cases.

Quote of note: “The burden on federal judges arising from any legislation that moves class actions to the federal courts has raised concerns among judicial administrators who express concern about the additional caseloads. Because of the added delays and expenses, the cumulative effect of the legislation may cultivate a new generation of stronger plaintiffs’ firms that can match their counterparts in size and expertise.”

Leave a comment

Filed under All The News That's Fit To Blog

Tut Systems Settles

Tut Systems, Inc. (Nasdaq: TUTS) has announced the preliminary settlement of the securities class action pending against the company in the N.D. of California (the company is also settling a related derivative case brought in California state court). According to an article on the settlement in the Oakland Tribune, Plaintiffs had alleged that the company’s financial results for the second and third quarters of 2000 “were false and misleading because the company failed to report a major recall of one of its products in the summer of 2000 that resulted in improperly recognized revenues on sales of defective products that were returned during the recall.”

The settlement of the securities class action, which is still subject to court approval, is for $10 million. The settlement of the derivative case involves Tut’s adoption of certain corporate governance measures and the payment of plaintiff’s legal fees and expenses. Both payments will be made by Tut’s insurance carrier.

Leave a comment

Filed under Settlement

Plaintiffs’ Bar Goes Global

As previously reported in The 10b-5 Daily, the number of securities class actions filed against foreign issuers has been on the rise. The Recorder has an article (via law.com – free regist. req’d) discussing this trend and the challenges posed by the cases.

Quote of note: “The suits represent a clash of business cultures. Few nations have financial regulations as stringent as those of the United States, and none has a plaintiffs bar as active. While American companies have grown used to investor class actions, viewing them as a cost of doing business, European executives see them differently.”

Leave a comment

Filed under All The News That's Fit To Blog